RACHEL SCRIMSHIRE: Open Payments
NPI 1093227423 · MALVERN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 7 payments from 5 companies in 2025. Trend: 2023 $69 · 2024 $137 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Organogenesis Inc. | 1 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, VIA MATRIX, AIRSUPRA, MOUNJARO, Qelbree.
Industry payments across AR — which companies pay providers there.
